Texts and cash incentives get teens with diabetes moving

NCT ID NCT04874415

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 35 times

Summary

This study tested whether daily text messages and financial incentives could motivate overweight teens and young adults with prediabetes or type 2 diabetes to be more physically active. Participants wore a Fitbit and received texts with personalized goals and either a small reward or a potential loss of money. The goal was to see if these behavioral tricks could increase daily steps and moderate-to-vigorous activity.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania, 15224, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

text messaging and financial incentives

What this could lead to

If successful, this approach could offer a low-cost, scalable way to help young people with diabetes become more active.

What could go wrong

This was a small, early-stage study (75 participants) testing a behavioral intervention, so results may not apply broadly. The effect on long-term health is unknown.

Conditions

The condition(s) this trial relates to.

Insulin Resistance polycystic ovary syndrome prediabetes syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.